Literature DB >> 12718823

Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.

J Garbino1, R Sommer, A Gerber, C Regamey, P Vernazza, D Gennè, P Dür, M Rothen, J P Unger, D Lew.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) is a common problem and the principal infection requiring hospitalization, but its treatment is complicated by the difficulty in microbiological diagnosis and the increasing incidence of antibiotic resistance among respiratory pathogens. The purpose of this paper is to present the main epidemiologic features of patients with CAP requiring hospitalization in our country.
METHODS: We enrolled three hundred and eighteen adult patients with CAP requiring hospitalization in seven large medical centers in Switzerland during two winter periods. The patients' mean age was 70.4 years. This study describes the epidemiology of these patients. Clinical, radiologic and microbiological evaluations were performed at study entry during treatment, and at 4 weeks post-therapy. For microbiological diagnostic purposes, sputum culture, throat swab culture, PCR, blood cultures, Legionella urinary antigen and serologic evaluations were also performed.
RESULTS: Despite the higher mean age, the overall mortality rate was 8%, lower than in other comparable studies. The most common underlying diseases present at study entry were cardiac failure (23%), chronic obstructive pulmonary disease (20%), renal failure (15%), and diabetes (12%); 40% of the patients were smokers. Although dyspnea, cough and positive pulmonary auscultation findings were present in about 90% of patients, fever >38 degrees C was present in only 64%. The most frequently isolated respiratory pathogens were Streptococcus pneumoniae (12.6%), Haemophilus influenzae (6%), Staphylococcus aureus (1.6%), and Moraxella catarrhalis (1.6%). Atypical pathogens were frequently found, with the following distribution: Mycoplasma pneumoniae, 7.5%; Chlamydia pneumoniae, 5.3%; and Legionella pneumophila, 4.4%. The mean duration between onset of symptoms and hospital admission was 4.8 days, and the mean treatment duration was 12.1 days. Two weeks after the start of therapy, although clinical symptoms were absent, radiologic infiltrates were still present in 24% of patients.
CONCLUSIONS: The microbiological diagnosis in CAP can be established in only about 50% of cases with the combination of several diagnostic tools. Epidemiologic surveys of CAP should be performed on a regular basis, regionally, as a way to improve the management of these infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12718823     DOI: 10.1016/s1201-9712(02)90163-3

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

Review 2.  Global Perspective of Legionella Infection in Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Frances F Graham; Norah Finn; Paul White; Simon Hales; Michael G Baker
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

3.  Respiratory viral infections and effects of meteorological parameters and air pollution in adults with respiratory symptoms admitted to the emergency room.

Authors:  Denise R Silva; Vinícius P Viana; Alice M Müller; Fernando P Livi; Paulo de Tarso R Dalcin
Journal:  Influenza Other Respir Viruses       Date:  2013-08-26       Impact factor: 4.380

4.  Lack of Chlamydia-related bacteria among patients with community-acquired pneumonia.

Authors:  N Garin; O Hugli; D Genné; G Greub
Journal:  New Microbes New Infect       Date:  2015-10-22

5.  Spectrum of respiratory viruses circulating in eastern India: prospective surveillance among patients with influenza-like illness during 2010-2011.

Authors:  Tapasi Roy Mukherjee; Shampa Chanda; Satarupa Mullick; Papiya De; Malay Dey-Sarkar; Mamta Chawla-Sarkar
Journal:  J Med Virol       Date:  2013-08       Impact factor: 2.327

6.  Atypical pneumonia--time to breathe new life into a useful term?

Authors:  David R Murdoch; Stephen T Chambers
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

Review 7.  Respiratory virus panels for global surveillance of emerging infectious diseases.

Authors:  Gary T Brice; Steven J Drews; Donald E Low
Journal:  J Clin Virol       Date:  2007-11       Impact factor: 3.168

8.  Frequency of detection of respiratory viruses in the lower respiratory tract of hospitalized adults.

Authors:  C Minosse; M Selleri; M S Zaniratti; G Cappiello; R Longo; E Schifano; A Spanò; N Petrosillo; F N Lauria; V Puro; M R Capobianchi
Journal:  J Clin Virol       Date:  2008-03-14       Impact factor: 3.168

Review 9.  Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.

Authors:  Daniel M Musher; Michael S Abers; John G Bartlett
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

10.  Legionnaires' Disease on the Rise in Switzerland: A Denominator-Based Analysis of National Diagnostic Data, 2007-2016.

Authors:  Fabienne B Fischer; Claudia Schmutz; Valeria Gaia; Daniel Mäusezahl
Journal:  Int J Environ Res Public Health       Date:  2020-10-08       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.